I want to start by thanking everyone who attended our NIHR Biomedical Research Centre (BRC) Showcase this month – I hope you gained a deeper understanding of the BRCs’ expertise and the opportunities for collaboration. And thank you to the eight BRCs and the Cell and Gene Therapy Catapult who made the day a success.
A new report from the European Patent Office has revealed that the number of UK pharma applications it received jumped 15.7% between 2017 and the previous year – narrowly behind the USA’s 17.6%. Earlier this week, at our latest Angels in MedCity workshop, Gill Jennings & Avery reminded investors that patents are not the only way to protect invention and innovation. Nevertheless, it is great to see this statistic because it shows that the UK continues to be a driver of new ideas and commercial opportunity. It was also fantastic to see that Oxford Nanopore, who star in our Genomics campaign, raised £100m to support its commercial expansion.
Just a reminder that applications for the DigitalHealth.London Accelerator programme will close on 13 April! So make sure you apply today for the chance to get 1:1 support from an NHS Navigator, with help to refine your product, gain market knowledge, and the opportunity to showcase your innovations. The Accelerator has now also expanded outside of London, to East Midlands, Manchester and South West England – read more here.
Finally, we are now starting to look towards London Tech Week in June and we are working with Health Foundry, DigitalHealth.London and Tech London Advocates Health Working Group on an event for start-ups and scale-ups. Find out how you can take part in the event or sign up to come along on the day here.
Thank you and I hope you have a great Easter break.